RFA-MD-24-009: Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
Closed
This grant is closed. A newer notice from the same program is forecast: Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional) (RFA-MD-27-001). Status: Expected deadline January 25, 2027. It is in our archive of National Institutes of Health notices from 2024.
National Institutes of Health offered grants to nonprofits and colleges and universities. Applications closed on August 2, 2024.
From the official notice on Grants.gov, last changed June 18, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU19
- Clinical trialsOptional
- Funded byNIMHD
- Median yearly award$653,499
- Typical project length4.5 years
- U19, Research Program Cooperative Agreement. Several related projects under one award, with substantial NIH involvement. Other open U19 notices.
Projects funded under RFA-MD-24-009 were run by National Institute on Minority Health and Health Disparities (NIMHD, 2 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-MD-24-009 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-MD-27-001 | July 16, 2026 | Expected deadline January 25, 2027 | Forecast |
Key dates
| Posted | June 17, 2024 |
|---|---|
| Deadline | August 2, 2024 |
| Archived by Grants.gov | September 7, 2024 |
Who can apply
This opportunity was open to nonprofits and colleges and universities.
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Is this a realistic fit?
- Most of the program's money (78% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Notice of Funding Opportunity (NOFO) is to support research that includes education, outreach, and clinical access to improve the screening, diagnosis, and treatment of cancers among American Indians and Alaska Natives, particularly those living in rural communities.
Funded under RFA-MD-24-009 so far
NIH funded 2 projects under RFA-MD-24-009 in fiscal 2024 to 2026, at 2 institutions. The median yearly award was $653,499.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Community Engagement with Dialogue, Advancement, and Research (CEDAR) Core | Fred Hutchinson Cancer Center | 2026 | $512,760 |
| Improving Cancer Outcomes in Native American Communities (ICON) - Community Engagement Core | University of Oklahoma HLTH Sciences Ctr | 2026 | $699,713 |
Who has won Minority Health and Health Disparities Research grants before
From fiscal 2021 to 2025, Minority Health and Health Disparities Research (93.307) awarded $2.0 billion across 1,237 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Maryland | 37 | $69.3 million |
| The Trustees of Columbia University in the City of New York | New York | 25 | $59.1 million |
| University of Hawaii | Hawaii | 18 | $52.8 million |
| The Regents of the University of California, San Francisco | California | 24 | $49.5 million |
| The Morehouse School of Medicine, Inc. | Georgia | 4 | $44.1 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, RFA-MD-27-001, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-MD-24-009 still open?
No. It closed on August 2, 2024. A newer notice is forecast: RFA-MD-27-001, expected deadline January 25, 2027.
Who can apply for Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits and colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)?
Closed August 2, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-MD-24-009?
NIH RePORTER lists 2 projects funded under RFA-MD-24-009 in fiscal 2024 to 2026, at 2 institutions. The most were at Fred Hutchinson Cancer Center, University of Oklahoma HLTH Sciences Ctr.
Who has won Minority Health and Health Disparities Research grants before?
The largest recipients over five fiscal years were The Johns Hopkins University, The Trustees of Columbia University in the City of New York, University of Hawaii. The program made 1,237 awards worth $2.0 billion in that time.
Similar open grants
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
- Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)